Subramaniam VN

Idioma: Ingles.
Referencias bibliográficas: 8
Paginas: 8-9
Archivo PDF: 116.29 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet 2016; 388: 706-16.

2. Britton LJ, Subramaniam VN, Crawford DH. Iron and non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22: 8112-22.

3. O’Brien J, Powell LW. Non-alcoholic fatty liver disease: is iron relevant? Hepatol Int 2012; 6: 332-41.

4. Handa P, Maliken BD, Nelson JE, Hennessy KA, Vemulakonda LA, Morgan-Stevenson V, Dhillon BK, et al. Differences in hepatic expression of iron, inflammation and stress-related genes in patients with non-alcoholic steatohepatitis. Ann Hepatol 2017; 16: 77-85.

5. Senates E, Yilmaz Y, Colak Y, Ozturk O, Altunoz ME, Kurt R, Ozkara S, et al. Serum levels of hepcidin in patients with biopsy- proven nonalcoholic fatty liver disease. Metab Syndr Relat Disord 2011; 9: 287-90.

6. Bonkovsky HL, Jawaid Q, Tortorelli K, LeClair P, Cobb J, Lambrecht RW, Banner BF. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999; 31: 421-9.

7. Severson TJ, Besur S, Bonkovsky HL. Genetic factors that affect non-alcoholic fatty liver disease: A systematic clinical review. World J Gastroenterol 2016; 22: 6742-56.

8. Lee J, Kim Y, Friso S, Choi SW. Epigenetics in non-alcoholic fatty liver disease. Mol Aspects Med 2016; pii: S0098-2997: 30090-5.